4.4 Review

Subjective cognitive impairment

Journal

CURRENT OPINION IN PSYCHIATRY
Volume 25, Issue 6, Pages 445-450

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/YCO.0b013e3283586fd8

Keywords

memory complaint; metamemory; subjective cognitive impairment; subjective memory impairment

Categories

Funding

  1. Pfizer
  2. Lundbeck
  3. Janssen pharmaceutical company
  4. Roche pharmaceutical company

Ask authors/readers for more resources

Purpose of review To describe the recent (2011-2012) literature relevant to subjective cognitive impairment (SCI), focusing principally on studies of this symptom in older age groups. This is an issue of growing importance: although the symptom itself is controversial in older people because of variable associations with objective cognitive impairment, it remains one of the few presenting complaints which may identify people experiencing early cognitive decline. Recent findings Several neuroimaging studies confirm earlier reports of associations between SCI and underlying abnormalities whereas those between subjective and objective cognitive function remain heterogeneous. Several studies now highlight the fact that, regardless of underlying associations, SCI as a symptom is associated with significant concern but is something for which older people rarely seek help. Summary Neuroimaging findings suggest that older people may be more aware of underlying brain changes than was previously apparent or than can be detected using conventional neuropsychological assessments. However, not all of these brain changes are necessarily progressive or neurodegenerative. At least some attention should be paid to interventions for what is a common, often distressing, but underreported symptom.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available